Ionis reports first quarter 2020 financial results and recent business achievements
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Ionis Pharmaceuticals (IONS) Misses Q1 EPS by 23c
May 6, 2020 7:14 AM EDTIonis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.35), $0.23 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $133 million versus the consensus estimate of $161.13 million.
On track to achieve 2020 financial guidance"We are reaffirming our 2020 financial guidance, including... More